NCT01867697 - Nordic 8 - A Phase II Trial | Biotech Hunter

Enrollment

173

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

Cetuximab

DRUG

Irinotecan

DRUG

Oxaliplatin

DRUG

Folinic Acid

DRUG

Calcium Carbonate

Trial Locations (12)

2100

Rigshospitalet, Copenhagen

2730

Herlev University Hospital, Herlev

4000

Roskilde Hospital, Roskilde

4700

Naestved Hospital, Næstved

5000

Odense University Hospital, Odense

5021

Haukeland University Hospital, Bergen

6700

Sydvestjysk Hospital, Esbjerg

8000

Aarhus University Hospital, Aarhus

9100

Aalborg University Hospital, Aalborg

Unknown

Herning Hospital, Herning

Trondheim University Hospital, Trondheim

751 85

Akademiska University Hospital, Uppsala

All Listed Sponsors

collaborator

Merck Serono International SA

INDUSTRY

lead

Per Pfeiffer

OTHER